RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+42.01%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$6.4B
AUM Growth
+$6.4B
(+26%)
Cap. Flow
+$71M
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
60.92%
Holding
71
New
5
Increased
8
Reduced
9
Closed
9
Top Buys
| 1 |
IMGN
Immunogen Inc
IMGN
|
$309M |
| 2 |
MacroGenics
MGNX
|
$35.7M |
| 3 |
C4 Therapeutics
CCCC
|
$27.6M |
| 4 |
UroGen Pharma
URGN
|
$24M |
| 5 |
Structure Therapeutics
GPCR
|
$19.8M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$77.1M |
| 2 |
Cogent Biosciences
COGT
|
$62.6M |
| 3 |
Soleno Therapeutics
SLNO
|
$36.6M |
| 4 |
Avidity Biosciences
RNA
|
$35.9M |
| 5 |
CureVac
CVAC
|
$33.1M |
Sector Composition
| 1 | Healthcare | 99.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arvinas
ARVN
$580M
| $17.3M | 0.27% |
+421,348
| New | +$17.3M |
|
|
HARP
52
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $17.1M | 0.27% |
+1,500,000
| New | +$17.1M |
|
|
BCYC
53
Bicycle Therapeutics
BCYC
$492M
| $14.5M | 0.23% |
800,000
| – | – |
|
|
54
CureVac
CVAC
$1.21B
| $11.6M | 0.18% |
2,744,270
-7,860,074
| -74% | -$33.1M |
|
|
CMPS
55
Compass Pathways
CMPS
$452M
| $11.3M | 0.18% |
1,286,000
| – | – |
|
56
Black Diamond Therapeutics
BDTX
$164M
| $9.91M | 0.15% |
3,525,754
| – | – |
|
|
CMRX
57
DELISTED
Chimerix, Inc.
CMRX
| $8.47M | 0.13% |
8,800,000
+2,298,376
| +35% | +$2.21M |
|
|
IGMS
58
DELISTED
IGM Biosciences
IGMS
| $7.79M | 0.12% |
937,500
| – | – |
|
|
CNTB
59
Connect Biopharma
CNTB
$111M
| $3.61M | 0.06% |
3,062,871
-3,928,132
| -56% | -$4.64M |
|
60
Unicycive Therapeutics
UNCY
$75.8M
| $3.01M | 0.05% |
347,069
| – | – |
|
61
SAB Biotherapeutics
SABS
$21.6M
| $1.63M | 0.03% |
+237,408
| New | +$1.63M |
|
62
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$64M
| $1.04M | 0.02% |
333,333
| – | – |
|
63
Aclaris Therapeutics
ACRS
$223M
| – | – |
-4,398,453
| Closed | -$30.1M |
|
64
Celcuity
CELC
$2.3B
| – | – |
-1,400,001
| Closed | -$12.8M |
|
|
65
Cogent Biosciences
COGT
$1.83B
| – | – |
-6,416,147
| Closed | -$62.6M |
|
66
EyePoint Pharmaceuticals
EYPT
$827M
| – | – |
-3,370,506
| Closed | -$26.9M |
|
67
Nektar Therapeutics
NKTR
$543M
| – | – |
-1,246,667
| Closed | -$11.1M |
|
|
68
Soleno Therapeutics
SLNO
$3.56B
| – | – |
-1,239,000
| Closed | -$36.6M |
|
69
Tourmaline Bio
TRML
$645M
| – | – |
-240,324
| Closed | -$6.75M |
|
70
Viridian Therapeutics
VRDN
$1.59B
| – | – |
-2,007,946
| Closed | -$30.8M |
|
|
NSTG
71
DELISTED
NanoString Technologies, Inc.
NSTG
| – | – |
-1,723,373
| Closed | -$2.96M |
|